Subgroup analyses of METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients (pts) with advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Escudier, B. J.; Motzer, R. J.; Powles, T.; Tannir, N. M.; Davis, I. D.; Donskov, F.; Grünwald, V.; Heng, D. Y. C.; Hutson, T.; Melichar, B.; Nosov, D.; Rini, B. I.; Salman, P.; Sternberg, C. N.; Szczylik, C.; Wolter, P.; Arroyo, A. M.; Mangeshkar, M.; Agarwal, N.; Choueiri, T. K. |
| Abstract Title: | Subgroup analyses of METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients (pts) with advanced renal cell carcinoma (RCC) |
| Meeting Title: | 2016 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2016 Jan 7-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-01-10 |
| Language: | English |
| ACCESSION: | WOS:000378109100492 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2016.34.2_suppl.499 |
| Notes: | Meeting Abstract: 499 -- Source: Wos |
